SF-539 In Vitro Boyden Chamber Assay (Angiogenesis)

This assay is to provide SF-539-based In Vitro Boyden Chamber Assay (Angiogenesis) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

SF-539

Human

The SF-539 cell line was isolated from a recurrent, right temporoparietal glioblastoma multiforme of a 34-year-old white female patient after the treatment.

Glioblastoma

Oncology

In Vitro Boyden Chamber Assay (Angiogenesis)

SF-539-cell based In Vitro Boyden Chamber Assay (Angiogenesis)

The Boyden chamber assay has been used to study angiogenesis by assessing endothelial cell migration.

Angiogenesis Monitoring Assays

Local and regional metastasis is a life-threatening condition in cancer, which is hard to control with the available cancer treatment options. In metastasis, cancer cells move away from primary tumors and travel through the blood and lymphatic system and form new tumors on other parts. A vascular
network growth is important for cancer metastasis. Angiogenesis is a process that is known as the formation of new blood vessels with the help of existing blood vessels and angiogenesis has been reported to play a major role in cancer growth and metastasis. Tumors can send chemical signals to nearby normal tissues to stimulate angiogenesis. New blood vessels can feed growing tumors with nutrients and oxygen, allowing cancer cells to spread (metastasis).